X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
https://www.globenewswire.com/news-release/2024/04/24/2868337/0/en/Alvotech-Announces-Topline-Results-from-a-Confirmatory-Clinical-Study-for-AVT05-a-Proposed-Biosimilar-for-Simponi-golimumab.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125289
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125289
https://pharmanewsintel.com/news/jj-ulcerative-colitis-clinical-trial-produces-high-rate-of-remission
https://www.prnewswire.com/news-releases/results-of-novel-clinical-study-of-guselkumab-and-golimumab-combination-therapy-show-adults-with-moderately-to-severely-active-ulcerative-colitis-maintained-higher-rates-of-clinical-histologic-and-endoscopic-remission-at-week-38-301644127.html
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-dksh-enters-pact-to-commercials-alvotech-biosimilars-in-philippines/articleshow/94052406.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://www.expresspharma.in/lupin-and-dksh-sign-exclusive-licensing-and-supply-agreement-to-market-five-biosimilar-candidates-in-philippines/
https://www.prnewswire.com/news-releases/results-of-novel-clinical-study-show-adults-with-moderately-to-severely-active-ulcerative-colitis-achieved-higher-rates-of-clinical-response-clinical-remission-and-endoscopic-improvement-at-12-weeks-with-guselkumab-and-golimumab-301486054.html
https://www.businesswire.com/news/home/20210608005454/en/Bio-Thera-Solutions-Initiates-Phase-III-Clinical-Trial-for-BAT2506-a-Proposed-Biosimilar-of-Simponi%C2%AE-Golimumab
https://www.prnewswire.com/news-releases/simponi-aria-golimumab-approved-by-the-us-food-and-drug-administration-for-active-polyarticular-juvenile-idiopathic-arthritis-and-extension-of-its-active-psoriatic-arthritis-indication-in-patients-2-years-of-age-and-older-301141976.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125433
https://endpts.com/icer-criticizes-cost-of-8-targeted-immune-modulators-for-uc-recommending-some-deep-discounts/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125289
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125433
https://www.businesswire.com/news/home/20190814005245/en/Bio-Thera-Solutions-Initiates-Phase-Clinical-Trial-BAT2506/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==
https://www.fiercebiotech.com/biotech/celsius-therapeutics-inks-first-biopharma-deal-ibd-study-janssen?utm_source=internal&utm_medium=rss
https://www.biospace.com/article/j-and-j-s-janssen-teams-with-celsius-therapeutics-in-ulcerative-colitis-study/
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-10-13-december-2018
Market Place
Share 
